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CI, 1.5-3.1), and 2.6% (95% CI, 1.8-3.5) respectively. 
Compared with subjects without chronic gastrointesti-
nal symptoms (n  = 1153), those with GERD (n  = 50), 
uninvestigated dyspepsia (n  = 166) and IBS (n  = 31) 
had significantly worse scores on most domains of the 
SF-36 scales.
CONCLUSION: The prevalence of GERD, uninvesti-
gated dyspepsia and IBS were 3.5%, 11.7% and 2.2% 
respectively, in the Korean population. The health-
related quality of life was significantly impaired in sub-
jects with GERD, uninvestigated dyspepsia and IBS in 
this community.
© 2008 The WJG Press. All rights reserved.
Key words: Chronic gastrointestinal symptom; Gastro-
esophageal reflux disease; Dyspepsia; Irritable bowel 
syndrome; Qaulity of life
Peer reviewer: Roger Jones, Professor, Department of General 
Practice and Primary Care, King’s College London, 5 Lambeth 
Walk, London SE11 6SP, United Kingdom
Jeong JJ, Choi MG, Cho YS, Lee SG, Oh JH, Park JM, 
Cho YK, Lee IS, Kim SW, Han SW, Choi KY, Chung IS. 
Chronic gastrointestinal symptoms and quality of life in the 
Korean population. World J Gastroenterol 2008; 14(41): 
6388-6394  Available from: URL: http://www.wjgnet.
com/1007-9327/14/6388.asp  DOI: http://dx.doi.org/10.3748/
wjg.14.6388
INTRODUCTION
Functional gastrointestinal disorders (FGIDs) are highly 
prevalent in different geographic populations and cause 
a variety of  gastrointestinal symptoms that greatly in-
convenience the affected individuals[1,2]. According to 
a household survey in the United States, 69% of  those 
questioned reported as having at least one of  twenty 
functional gastrointestinal symptoms in the preceding 
three months[1]. In other population-based surveys, the 
prevalence of  non-ulcer dyspepsia was approximately 
30% and irritable bowel syndrome was 15%[2,3]. The 
prevalence of  functional gastrointestinal disorders has 
been reported to differ based on the geographical region 
and race. Although the prevalence of  such disorders in 
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Abstract
AIM: To evaluate the prevalence of chronic gastroin-
testinal symptoms and their impact on health-related 
quality of life (HRQOL) in the Korean population. 
METHODS: A cross-sectional survey, using a reliable 
and valid Rome Ⅱ based questionnaire, was per-
formed on randomly selected residents, between 18 
and 69 years in age. All respondents were interviewed 
at their homes or offices by a team of interviewers. 
The impact of chronic gastrointestinal symptoms on 
HRQOL was assessed using the Korean version of the 
36-item Short-Form general health survey (SF-36).
RESULTS: Of the 1807 eligible subjects, 1417 (78.4%: 
male 762; female 655) were surveyed. Out of the 
respondents, 18.6% exhibited at least one chronic 
gastrointestinal symptom. The prevalence of gastro-
esophageal reflux disease (GERD), defined as heart-
burn and/or acid regurgitation experienced at least 
weekly, was 3.5% (95% CI, 2.6-4.5). The prevalence 
of uninvestigated dyspepsia, irritable bowel syndrome 
(IBS) and chronic constipation based on Rome Ⅱ cri-
teria were 11.7% (95% CI, 10.1-13.5), 2.2% (95% 
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Koreans is thought to be different from that in the West-
erners, there has been no randomly sampled population-
based study on the prevalence of  chronic gastrointestinal 
symptoms in the Korean population.
The health-related quality of  life (HRQOL) is a 
patient-focused concept, referring to an impairment of  
functional status (physical or mental) and the sense of  
well-being. As such, it is an important measure of  the 
impact of  chronic diseases. Several studies have shown 
that the HRQOL is significantly reduced in patients with 
chronic gastrointestinal symptoms in referral settings, 
compared with the general population, as well as in pa-
tients with other chronic conditions, such as GERD and 
asthma. However, there is a lack of  evidence to support 
a decrease in the HRQOL in the general population hav-
ing chronic GI symptoms[4,5].
The aims of  the present study were to evaluate the 
prevalence of  chronic gastrointestinal symptoms accord-
ing to the Rome Ⅱ criteria, and to determine whether 
the HRQOL is impaired in subjects having chronic gas-
trointestinal symptoms in the Korean community.
MATERIALS AND METHODS
Subjects
The study was carried out in Asan-si, Chungchungnam-
do Province from January 3, 2000 to February 28, 2001. 
Asan-Si is a small city located in the middle of  South 
Korea. The population comprises approximately 180 000 
people, and is a combination of  urban and farming com-
munity. Sociodemographic factors including age, sex, ed-
ucational background and economic level of  Asan-si are 
similar to the overall Korean population, based on the 
information obtained from the Korean National Statisti-
cal Office (http://www.nso.go.kr). We assumed a symp-
tom prevalence of  40%; thus at least 1024 interviews 
were required to achieve the required precision of  ± 3% 
with 95% confidence. Therefore, the target sample size 
was 1400. A cross-sectional survey was performed on 
randomly selected Asan-si residents, between 18 and 69 
years of  age. A lengthy consultation was made with the 
regional health office (RHO) to prepare the survey. For 
instance, the general regional information provided by 
the RHO helped to organize visits and complete other 
administrative activities. Ten out of  Asan-si’s 17 districts, 
with population size over 500 were randomly selected. 
Within each of  these districts, a total of  200 households 
from every third street were chosen. The size, gender 
and age of  all household members were obtained from 
the RHO database before the visit. Gender and age were 
used to stratify the households and one person in each 
household was selected by random sampling, before a 
list of  selected individuals was compiled in each stratum. 
The regional health office checked the eligibility of  the 
selected individuals by examining their medical records, 
followed by a telephone interview. Exclusion criteria in-
cluded pregnant or lactating women, history of  surgery 
of  the GI tract including partial resection of  the stom-
ach and/or resection of  the small/large intestine (subjects 
with an appendectomy were included), major psychosis, 
mental retardation or dementia, significant illness that 
may render them unable to complete the questionnaire, 
or had other nationalities. The revised list was used for 
actual household visit after excluding the ineligible in-
dividuals. Since only housewives and elderly individuals 
would be available during the day, we pre-scheduled the 
time and order of  the house visits with the help of  the 
regional health office.
Questionnaire
We developed a bowel symptom questionnaire to iden-
tify chronic gastrointestinal symptoms in adults, based 
on the Rome Ⅱ criteria. The complete questionnaire 
was 22 pages long and included 130 questions, of  which 
103 were used to diagnose gastroesophageal reflux and 
chronic gastrointestinal symptoms. The bowel symp-
toms questionnaire was modified from the Mayo version 
of  Bowel Symptoms Questionnaire[6] and several items 
were adopted from the Rome Ⅱ criteria. The validation 
process consisted of  forward and backward translation 
as well as confirming the patient’s ability to understand. 
However, we did not perform test-retest reliability, be-
cause this was not a self-reported questionnaire, and 
trained interviewers visited homes and helped the sub-
jects to complete the questionnaire. During the survey, 
a face-to-face interview was conducted to help describe 
certain parts of  the Bowel Symptoms Questionnaire. 
Specifically, heartburn is not a term in the Korean 
language; therefore the symptoms had to be verbally 
described and a diagram indicating the location of  the 
burning sensation was added to the questionnaire in or-
der to help ensure that the subjects fully comprehended 
the medical conditions under investigation. The remain-
ing 27 questions enquired about the sociodemographic 
characteristics, self-reported height and weight, physician 
visits, past illnesses, social habits (smoking, alcohol, and 
medication use), impact on everyday life, possible anxiety 
induced by the problem, as well as lifestyle changes that 
may have been relevant.
HRQOL was assessed by the Korean version of  
SF-36 (SF-36-K). We previously assessed the reliability, 
discriminant validity and concurrent validity of  the SF-
36-K before conducting this study. The SF-36-K was 
fully applicable and well understood by Korean patients, 
as well as healthy subjects. The reliability was assessed 
by using the test-retest method, and the internal con-
sistency method. The test-retest method showed high 
correlation between the two tests. Cronbach’s correla-
tion alpha of  all 8 subscales of  the SF-36-K was > 0.73 
(range, 0.73-0.96). Discriminant validity was supported 
by comparing the SF-36 score in 179 healthy subjects 
and 44 patients with gastrointestinal disorders. All 8 
domains of  the SF-36 were well correlated with sub-
scores of  the WHO Quality of  Life Scale-K and the 
Psychological Well-Being Index. The SF-36 is a widely 
used general health profile questionnaire with 36 ques-
tions comprising eight scales: physical functioning (e.g. 
walking, lifting), role functioning-physical (limitations 
in ability to perform usual activities), role functioning-
emotional (impact of  emotional problems on work or 
daily activities), social functioning (impact of  health or 
emotional problems on social activities), bodily pain (level 
of  bodily pain or discomfort), mental health (anxiety, 
depression, sense of  psychological well-being), vitality 
(energy level or fatigue), and general health perceptions 
(global evaluations of  health). The SF-36 is scored from 
0 to 100 with higher scores indicating a better HRQOL.
Survey design
We conducted a cross-sectional survey of  gastrointes-
tinal symptoms and their impact on the quality of  life 
(QOL) in Korean subjects in cooperation with the pub-
lic health center. Before the survey, the questionnaire 
was explained to the health-care personnel of  the Public 
Health Center to outline the purpose of  the study and to 
request their participation. All subjects were interviewed 
in person at their homes or offices by a team of  inter-
viewers, all trained by the same physician (C.M.G.). The 
consistency and completeness of  the completed ques-
tionnaire was checked after each interview.
Statistics
The 1807 eligible individuals interviewed can be consid-
ered as a representative sample of  the Asan-si population. 
We calculated the prevalence of  GERD and chronic gas-
trointestinal symptoms according to the Rome Ⅱ criteria. 
The prevalence is presented in percentages with 95% ex-
act confidence intervals (CI). Comparisons among groups 
were performed by the χ2 test or Fisher’s exact test for 
categorical data and t-test for continuous data. The asso-
ciation between prevalence rate and age in each group was 
tested by logistic regression model. Differences of  SF-36 
sub-scale scores between groups were estimated by AN-
COVA model with adjustment of  covariates. Pair-wise dif-
ferences between groups without chronic GI symptoms 
and groups with chronic GI symptoms (GERD, UD and 
IBS) were tested by Bonferroni adjusted t-test. Gender, 
age, economic level and education variables were used for 
adjustment. A multiple regression model was performed 
for SF-36 sub-scale scores for individuals who had chronic 
GI symptoms. Gender, age, smoking, religion, education, 
economic level, physician visit and overlapping symptom 
variables were used as predictors. Statistical analyses were 
performed using SAS (SAS, Cary, NC, USA). 
RESULTS
Response rate and subject characteristics
Among the randomly selected 2024 subjects, a total of  
217 were not eligible to participate in the study. One 
hundred and twenty individuals were no longer living in 
Asan-si and 97 could not be interviewed due to physical 
or mental disorders. Out of  the 1807 eligible subjects, 
314 could not be contacted after three attempts, and 76 
refused to participate. A total of  1417 (78.4%) of  the 
1807 eligible subjects returned the completed survey. Of  
these respondents, 762 were male (53.8%) and 655 were 
female (46.2%), with a mean age of  44 years. The demo-
graphic and socioeconomic features of  the respondents 
are shown in Table 1.
Prevalence of chronic gastrointestinal symptoms
The prevalence of  weekly episodes of  heartburn and 
acid regurgitation was 2.0% (95% CI, 1.2-2.7) and 2.0% 
(95% CI, 1.3-2.8) respectively. The prevalence of  GERD, 
defined as heartburn and/or acid regurgitation experi-
enced at least weekly, was 3.5% (95% CI, 2.6-4.5). The 
prevalence of  specific chronic gastrointestinal symptoms, 
according to the Rome Ⅱ criteria is summarized in Table 
2. At least one chronic gastrointestinal symptom was pres-
ent in 18.6% of  the 1417 respondents. The most preva-
lent chronic gastrointestinal symptom was uninvestigated 
dyspepsia (11.7%; 95% CI, 10.1-13.5). According to the 
subtypes of  dyspepsia, dysmotility-like dyspepsia was the 
most prevalent (69.9%), followed by ulcer-like dyspepsia 
(28.3%) and non-specific dyspepsia (1.8%). Thirty one 
subjects (2.2%) fulfilled the Rome Ⅱ criteria for the diag-
nosis of  IBS (Table 2). Of  these, 13 subjects (42%) were 
classified as diarrhea-predominant, and 12 (39%) consti-
pation-predominant IBS. The remaining 6 subjects (19%) 
fell into the alternating IBS subgroup. There were no dif-
ferences in the overall prevalence of  IBS based on gender; 
however, compared to male subjects, females reported 
more frequent constipation-predominant IBS (IBS-C). Fe-
males also reported more frequent chronic constipation. 
There were no gender-based differences in the prevalence 
of  the other chronic gastrointestinal symptoms (Table 2).
Age-specific prevalence of  GERD, uninvestigated 
dyspepsia, and IBS are shown in Figure 1, and the odds 
ratio with 95% confidence interval are shown in Table 3. 
The prevalence of  GERD and dyspepsia showed signifi-
cant differences between different age groups (logistic 
regression, P < 0.01).
Physician visit and medication use
In the present population-based study, 50.5% of  the 
Table 1  Characteristics of the study population  n  (%)
Variable Male Female Total
(n  = 762) (n  = 655) (n  = 1417)
Age
   18-29   163 (11.5)   151 (10.7)   314 (22.2)
   30-39 132 (9.3) 110 (7.8)   242 (17.1)
   40-49   169 (11.9)   146 (10.3)   315 (22.2)
   50-59   150 (10.6) 116 (8.2)   266 (18.8)
   60-69   148 (10.4) 132 (9.3)   280 (19.7)
Median age (yr) 45 44 44
Mean age (yr) 44.1 ± 14.4 43.7 ± 15.1 43.9 ±14.8
BMI (kg/m2)   22.8 22.0 22.4
Ever tobacco smoker (%)     67.8a   4.0 38.3
Alcohol use (> 75 g/wk) (%)     36.4a   2.6 20.7
Marital status (single)1 (%)   26.5 28.7 27.5
Employed (%)     85.4a 45.6 67.0
Presence of religion (%)     50.5b 65.0 57.2
High school graduate (%)     57.0a 49.2 53.4
Economic status (%)
   High      6.4   6.3   6.4
   Middle    76.1 79.8 77.8
   Low    17.5 13.9 15.8
1Marital status was divided into single or married/living as a couple. Single 
status was extended to include unmarried persons, divorced individuals 
and those with a deceased spouse aP < 0.01, bP < 0.001 compared to female.
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subjects surveyed had experienced at least one gastro-
intestinal symptom in the previous year, and 10.9% had 
reported visiting a physician due to their gastrointestinal 
symptoms. With regard to the use of  medications, 5.7% 
of  the respondents took non-steroidal anti-inflammatory 
drugs (NSAIDs), and 5.5% had taken anti-acid agents 
or antacids in the past year. More women took NSAIDs 
and constipation medications (Table 4).
Impact of chronic gastrointestinal symptoms on health-
related quality of life
Of  the 1417 respondents, 1153 individuals did not ex-
perience any chronic GI symptoms, while 198 subjects 
had features suggestive of  GERD, UD or IBS, or a 
combination of  these symptoms. There was no signifi-
cant difference between the two groups with respect 
to gender, smoking, martial status and BMI (P > 0.05). 
However, age, education level and the number of  physi-
cian visits were statistically different (P < 0.001). The 
mean age of  subjects with chronic GI symptoms and 
subjects without chronic GI symptoms was 47.8 ± 14.9 
and 43.0 ± 14.6, respectively. Subjects with chronic GI 
symptoms had a lower education level, and also visited a 
physician more frequently for gastrointestinal symptoms 
than subjects without chronic GI symptoms. SF-36 sub-
scale scores were calculated for four groups: (1) subjects 
without chronic gastrointestinal symptoms, (2) subjects 
with GERD, (3) subjects with uninvestigated dyspepsia, 
and (4) subjects with IBS. The adjusted mean scores 
for gender, age, education and economic level, as well 
as the accompanying P-values for the eight domains of  
the SF-36 are summarized in Table 5. Compared with 
those not experiencing chronic gastrointestinal symp-
tom, subjects with GERD exhibited significantly worse 
scores on all except two domains (social-functioning and 
role-emotional). Subjects with uninvestigated dyspepsia 
and IBS had significantly worse scores on all domains 
compared with those not having chronic gastrointestinal 
symptoms (Table 5). Multiple regression analysis of  the 
association between the HRQOL and covariates was 
performed on subjects with chronic GI symptoms (n = 
198) (Table 6). All covariates shows VIF smaller than 10, 
thus no covariates were excluded as the cause of  multi-
Figure 1  Age specific prevalence rate (per 100) of GERD, UD and IBS in 
Asan-si, Korea. GERD: Gastroesophageal reflux disease; UD: Uninvestigated 
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Table 2  Prevalence of chronic gastrointestinal symptoms, 
according to the Rome Ⅱ criteria
Respondent Male Female
(n  = 1417) (n  = 762) (n  = 655)
Chronic gastrointestinal 
symptoms
  n % (95% 
exact CI)
% %
Globus     7   0.5 (0.2-1.0)    0.4    0.7
Chronic dysphagia     7   0.5 (0.2-1.0)    0.3    0.7
Rumination     0   0.0 (0.0-0.3) 0 0
Chronic chest pain   21   1.5 (0.9-2.3)    1.6    1.4
Chronic heartburn   24   1.7 (1.1-2.5)    1.8    1.6
Uninvestigated 
dyspepsia
166 11.7 (10.1-13.5)  10.8  12.8
IBS   31   2.2 (1.5-3.1)    1.8    2.6
   IBS-D   13   0.9 (0.5-1.6) 1    0.8
   IBS-C   12   0.8 (0.4-1.5)    0.1     1.7a
   IBS-A     6   0.4 (0.2-0.9)    0.7    0.2
Chronic bloating   57   4.0 (3.1-5.2)    2.9    5.3
Chronic constipation   37   2.6 (1.8-3.6)    0.5     5.0a
Chronic diarrhea   11   0.8 (0.4-1.4)    0.8    0.8
Chronic incontinence   18   1.3 (0.8-2.0)    1.6    1.1
IBS: Irritable bowel syndrome; IBD-D: Diarrhea-predominant IBS; IBS-C: 
Constipation- predominant IBS; IBS-A: Alternating constipation and 
diarrhea IBS. aP < 0.05 (Fisher’s exact test) compared to male.
Table 3  Association between age and chronic gastrointestinal 
symptoms
Age      GERD        UD        IBS
18-29 1.0 (Reference) 1.0 (Reference) 1.0 (Reference)
30-39 0.48 (0.13-1.82) 2.12 (1.19-3.77) 1.15 (0.44-3.04)
40-49 1.14 (0.44-3.00) 1.39 (0.77-2.50) 0.56 (0.18-1.68)
50-59 1.23 (0.46-3.33) 2.28 (1.30-4.02) 0.68 (0.22-2.04)
60-69 3.30 (1.44-7.54) 3.00 (1.75 -5.14) 0.50 (0.15-1.63)
Values are shown as odds ratio and 95% confidence interval. GERD, 
gastroesophageal reflux disease; UD, uninvestigated dyspepsia; IBS, irritable 
bowel syndrome.
Table 4  Details of physician visits and use of medications  n  (%)
Variables      Men    Women     Total
(n  = 762) (n  = 655) (n  = 1417)
Experience (%) of any 
GI symptoms
366 (48.0) 351 (53.6)a   50.50
Experience (%) of visiting 
a physician due to 
GI symptoms
  80 (10.5)  75 (11.5) 155 (10.9)
1-2/yr   42 (5.5) 47 (7.2)   89 (6.3)
3-5/yr   12 (1.6) 12 (1.8)   24 (1.7)
6-10/yr     8 (1.0)   4 (0.6)   12 (0.8)
> 10/yr   18 (2.4) 12 (1.8)   30 (2.1)
Use of medications
   NSAIDs   27 (3.5)  54 (8.2)b   81 (5.7)
   Antacids   35 (4.6) 28 (4.3)   63 (4.5)
   H2RA   11 (1.4)   4 (0.6)   15 (1.1)
   Medications for 
   constipation
  17 (2.2)  49 (7.5)b   66 (4.7)
   Antihypertensive 
   medications
  17 (2.2) 18 (2.7)   35 (2.5)
aP < 0.05, bP < 0.01 compared to male.
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collinearity. The results of  overall F-test were significant 
for all models (P < 0.05). Female gender, old age, a low 
level of  education (< high school education), a low eco-
nomic class, number of  physician visits within the past 
year, and overlapping chronic gastrointestinal symptoms 
were associated with reduction in the SF-36 scales.
DISCUSSION
The present population-based study describes the preva-
lence of  chronic gastrointestinal symptoms and their 
impact on the HRQOL in the Korean population.
Heartburn and acid regurgitation are specific symp-
toms of  GERD, and a diagnosis of  GERD can be made 
on the basis of  these symptoms alone without further 
diagnostic tests[7]. When defined as “at least weekly 
heartburn and/or acid regurgitation”, the prevalence 
of  GERD in the West ranges between 10% and 20%, 
whereas in Asia the prevalence is reported to be < 5%[8]. 
In the present study, the prevalence of  GERD was 
found to be 3.5% which is much lower than that in West-
ern countries. According to two previous population 
studies in Korea, the prevalence of  GERD was 5% and 
7.1%, respectively[9,10]. It is unclear why the prevalence of  
GERD is lower in Korea compared to the West. Differ-
ences in the intake of  dietary fat, body build, genetic fac-
tors, and the prevalence of  H pylori infection are possible 
contributing factors[11]. The prevalence of  dyspepsia has 
been shown to vary considerably between different pop-
ulations. Although our data may represent the presence 
of  valid epidemiological differences, it is also possible 
that the varying definitions used in different population-
based studies may have contributed to this discrepancy. 
In the present study, the prevalence of  uninvestigated 
dyspepsia by Rome Ⅱ criteria was 11.7%. These results 
are similar to a study from Taiwan, which reported 
prevalence of  functional dyspepsia (FD) by the Rome Ⅱ 
criteria as 11.8%[12]. Population-based studies in Australia 
and Mexico have reported prevalence rates of  dyspepsia 
by Rome Ⅱ criteria of  24.4%[13] and 8.0%[14], respective-
ly. Based on Rome Ⅱ criteria, a patient presenting with 
upper abdominal pain or discomfort that is exclusively 
relieved by defecation and/or is associated with a change 
in the bowel pattern is defined as IBS rather than dys-
pepsia plus IBS[15]. Accordingly, many of  the previously 
Rome I-defined dyspepsia subjects should be reclassified 
as IBS, rather than IBS with dyspepsia. Furthermore, pa-
tients with predominant heartburn should be excluded. 
Although, the present study could not demonstrate the 
prevalence of  dyspepsia defined by RomeⅠcriteria, the 
prevalence of  dyspepsia by Rome Ⅱ criteria was lower 
compared to our previous study using the RomeⅠcrite-
ria (11.7% vs 15.5%)[9]. Reduction in prevalence has also 
been reported in other studies that directly compared 
the prevalence of  dyspepsia using RomeⅠand Rome 
Ⅱ criteria[12,13,16]. Several individuals who did not meet 
Rome Ⅱ criteria for dyspepsia were taking medications 
such as antacids, prokinetic agents and digestives for a 
long time. If  medication alone was indicative of  dyspep-
sia, our study indicates that its prevalence would be 16%. 
It is also possible that some subjects had GERD and not 
dyspepsia, or there was an overlap. One of  these factors 
may also account for the low prevalence of  GERD in 
the Korean population. Over-the-counter medications 
may explain the underestimation of  the prevalence of  
other functional GI disorders. Conversely, a number 
of  drugs can theoretically induce bowel symptoms. 
However, data supporting the role of  drugs, aside from 
NSAIDs, in the development of  bowel symptoms in the 
general population are lacking[17,18].
The prevalence of  IBS in Asian population-based 
studies has generally been lower compared to in the 
Table 5  Comparison of SF-36 subscales between subjects 






(n  = 1153)
GERD UD IBS
(n  = 50) (n  = 166) (n  = 31)
Physical 
functioning
87.6 ± 5.1  76.0 ± 6.2b 81.7 ± 5.4b   82.0 ± 66.8a
Role physical   80.1 ± 10.3    64.9 ± 12.4b   68.1 ± 10.9b   67.3 ± 13.7a
Bodily pain 89.3 ± 6.7  74.6 ± 8.1b 76.5 ± 7.1b 77.7 ± 8.9b
General health 68.8 ± 7.0  49.3 ± 8.5b 52.7 ± 7.5b 50.0 ± 9.4b
Vitality 57.6 ± 7.5  50.0 ± 9.0a 51.0 ± 7.9b   45.9 ± 10.0b
Social 
functioning
92.0 ± 4.9 88.3 ± 5.9 86.2 ± 5.2b 86.7 ± 6.6a
Role 
emotional
  86.2 ± 10.4 80.7 ± 12.5 77.7 ± 11.0b   71.7 ± 13.8b
Mental health 77.7 ± 6.2 67.9 ± 7.5b 71.6 ± 6.6b  66.1 ± 8.3b
Note: Age, gender, education level and economic level adjusted mean and 
95% confidence interval of SF-36 subscale. CGIS: Chronic GI symptom; 
GERD: Gastroesophageal reflux disease; UD: Uninvestigated dyspepsia; 
IBS: Irritable bowel syndrome. Comparisons were performed between 
GERD vs no CGIS, dyspepsia vs no CGIS, and IBS vs no CGIS. P value was 
adjusted by Bonferroni method. aP < 0.05 compared to subjects without 
chronic gastrointestinal symptom; bP < 0.01 compared to subjects without 
chronic gastrointestinal symptom. 
Table 6  Multiple regression results: estimated coefficient of 
predictors of each SF-36 subscale domain
Variable  PF  RP  BP  GH VT SF RE MH
Female sex -4.6 -9.6 -4.7 -5.3b -4.3a -3.6 -8.2 -1.8
Age1 -5.7c -3.2 -1.3 -4.6b -3.2a -1.4 -1.2 -3.5b
Ever smoking  2.5  3  2 -2.6  2.3  2.4  3  1.3
Religion  4.1  9.7 -0.1  1.3  6.5a -3.5 -3.5  2.3
< high school 
education
-6.7a -5.8 -3  2.6  3.1  0.4  3.8  4.2
Low economic 
class








-4.7 -3.5 -8.3a -6.9  1.6 -3.9 -5.5 -8.3b
R2  0.375  0.134  0.165  0.19  0.09  0.09  0.124  0.177
PF: Physical function; RP: Role-physical; BP: Bodily pain; GH: General 
health; VT: Vitality; SF: Social function; RE: Role-emotion; MH: Mental 
health. 1Age variables are categorized by 10 yr intervals; 2Number of 
physician visits for gastrointestinal symptoms: 0/yr(0), 1-2/yr(1), 3-5/
yr(2), 6-10/yr(3), > 10/yr(4). aP < 0.05; bP < 0.01; cP < 0.001.
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West, regardless of  the criteria applied. The prevalence 
of  IBS by Rome Ⅱ criteria has been reported to vary 
from 4.7% to 25% in the West and from 3.7% to 19.1% 
in Asia[19]. In the present study, the prevalence of  IBS 
by Rome Ⅱ criteria was 2.2%. In addition, the overall 
prevalence of  IBS was similar among men and women; 
however, the prevalence of  constipation-predominant 
IBS was higher in women. There is typically a significant 
female predominance with respect to hospital visits by 
IBS patients in Western countries, but this trend is not 
consistent with community studies and has been attribut-
ed to gender differences in health care utilization[19]. In a 
recent systematic review of  13 studies on IBS, based on 
Rome Ⅱ criteria, 7 studies found a higher prevalence of  
IBS in females and 4 studies found no gender difference, 
as in the present study[19]. A possible explanation for the 
lower female to male ratio in IBS in Koreans may be that 
men encounter more socioeconomic problems, causing 
increased stress and, as a consequence, an increased level 
of  IBS[20].
In the present study, we also examined the impact 
of  GERD, and two common chronic gastrointestinal 
symptoms (uninvestigated dyspepsia and IBS) on the 
HRQOL. Although a number of  studies suggest that the 
HRQOL is significantly reduced in patients with chronic 
gastrointestinal symptoms in a referral setting, the data 
are conflicting[21], and very few studies have evaluated 
the impact of  chronic gastrointestinal symptoms on 
HRQOL in the general population. In the present study, 
we observed that the quality of  life was significantly im-
paired in subjects with GERD, uninvestigated dyspepsia 
and IBS. These findings are consistent with previous 
studies[5,22-24].
The present study showed that old age, female gen-
der, the number of  physician visits per year and pres-
ence of  overlapping symptoms were associated with a 
negative impact on several domains of  the SF-36. In 
general, old age was associated with a less favorable as-
sessment of  their personal health, pessimistic health 
appraisal, social isolation and unemployment[25]. Few 
studies have investigated whether women and men with 
chronic gastrointestinal symptoms differ with respect 
to the HRQOL measures. In a study based on referral 
center and primary care patients, Simren et al[26] observed 
that women with IBS had lower HRQOL compared to 
men with IBS. In another study, Lee et al[27] also found 
that women with IBS reported lower HRQOL scores. In 
the present study, a greater number of  hospital visits was 
associated with a poorer HRQOL, which is in agreement 
with a US population-based study[28]. Fifty five percents 
of  subjects with IBS had sought health care in the past 
year, and subjects with IBS had significantly lower IBS-
QOL scores in the mental health and social functioning 
domains[28].
The strengths of  the present study were inclusion of  
a random population sample, and the use of  personal 
interviews with the subjects. As a result, we obtained 
a high response rate (78.4%), avoided a significant re-
sponse bias, and had a negligible number of  missing 
values. Since the interviewers associated with this study 
were trained before the commencement of  contact with 
the subjects, a uniform survey was possible due to the 
fact that the interviewers could explain each aspect of  
the questionnaire fully, especially to subjects who were 
old, had low education level, or those who could not un-
derstand certain items. Sociodemographic factors includ-
ing age, gender, educational background and economic 
level of  the individuals in Asan-si were similar to the 
Korean population, based on the information obtained 
from the Korean National Statistical Office. Asan-si is 
a combined urban and farming community. We selected 
10 out of  the 17 districts of  Asan-si. Five districts were 
randomly chosen in urban areas and the remaining five 
were selected in rural areas, which may have limited the 
generalization of  the study. However, no differences 
were found between the demographic factors and the 
prevalence of  GI symptoms in the 10 districts, and be-
tween rural and urban areas.
In summary, we evaluated the prevalence of  chronic 
gastrointestinal symptoms in the Korean general popula-
tion and demonstrated a significant impact of  chronic 
gastrointestinal symptoms on the HRQOL. Dyspepsia 
was found to be the most common chronic gastrointes-
tinal symptom, and the prevalence of  GERD and IBS 
was lower compared to in the West. The presence of  
chronic gastrointestinal symptoms was found to have a 
negative impact on the HRQOL. This negative impact 
was greater in females, the elderly, individuals of  lower 
economic class, and in subjects with higher number of  
physician visits, and overlapping symptoms.
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